Home | Alzheimer's Drug Discovery Foundation

A Path Towards Hope

2019 illustrated how the ADDF has been at the forefront, leading the way towards an Alzheimer’s cure.

ADDF Launches New Phase of Diagnostics Accelerator

Powering the Next Generation of Alzheimer’s Precision Medicine Worldwide

ADDF Appoints Isobel Coleman as Chief Executive Officer to Lead Next Era of Alzheimer's Breakthroughs

Landmark Biomarker Observatory Paper Offers First Comprehensive View of Biomarker Use Across Alzheimer’s Clinical Trials

Learn More

ADDF Awards Prestigious 2026 Melvin R. Goodes Prize to Alzheimer’s Research Pioneer Randall J. Bateman, MD

Learn More

Make a Difference

Join us in supporting the most promising Alzheimer's research around the world through our Milestones in Motion campaign.

Give Now

Research Update:

New Semaglutide Data Offers Key Insights for Next Generation Alzheimer’s Therapies

Learn More

Research Update:

Leqembi Receives First FDA Approval for Subcutaneous Formulation for Alzheimer’s

Learn More

Gates Notes:

Welcome to the next phase of the Alzheimer’s fight

Learn More

In Memoriam: Leonard A. Lauder

Visionary philanthropist in the fight against Alzheimer's

Learn More

The Economist Points to Robust and Diverse Drug Pipeline as Reason for Optimism

In a recent article, The Economist spotlights the increasingly diverse pipeline of Alzheimer’s treatments informed by the Biology of Aging, with 4 in 5 drugs currently in development focused on novel targets, citing the ADDF's Clinical Trials Report.

Read Now